Search Results 21-30 of 161 for ✔토지노추천 【위너보증.com / 가입코드 9122】 sbc주소 ✔

  1. Px Code,Supply #,Description,Unit Price 278000024,48589,CATH ABL THRMCL ST FJ,"5,504.00" 278000026,70189,CATH SWN DLYS PERIT 14FX62.5,338.5 278000027,103611 ...

  2. ADJUSTING SIGNIFICANCE LMELS IN CENSORED DATA WHEN USING MULTIPLE TESTS SIMULTANEOUSLY by THOMAS R. FLE!YING and DAVID P. YARRIN

    ... No. 11. December 1980. Page 2. FINAL REPORT. ADJUSTING SIGXIFICARCE LEVELS IN CENSORED DATA. WREN USIi'?G MULTIPLE TESTS SIMULTANROUSLY. Submitted to. Ebon ...

  3. BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  4. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  5. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  6. Px Code,ID,Description,Unit Price 636000003,5197101,pneumococcal 13-val conj vaccine-dip crm (PF) 0.5 mL IM syringe,281.39 636000003,5197102,pneumococcal 13 ...

  7. A Study of STX-0712 in Patients with Advanced Hematologic Malignancies - Mayo Clinic

    ... no further treatment options known to confer clinical benefit. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  8. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  9. A Study to Evaluate the Safety and Tolerability of DCC-2618 in Patients with Advanced Malignancies - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  10. DN24-02 as Adjuvant Therapy in Subjects with High Risk HER2+ Urothelial Carcinoma - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...